Spots Global Cancer Trial Database for gastrointestinal stromal tumor

Every month we try and update this database with for gastrointestinal stromal tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination	NCT01613053	Gastrointestina...	Glivec	18 Years -	Novartis
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery	NCT00025246	Gastrointestina...	imatinib mesyla... laboratory biom...	16 Years -	National Cancer Institute (NCI)
Laparoscopic Resection of Large Gastric Stromal Tumors	NCT02662478	Gastrointestina...	Laparoscopic Su...	18 Years -	Medical Park Gaziantep Hospital
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors	NCT00372567	Gastrointestina...	sunitinib malat... imatinib mesyla...	18 Years -	Pfizer
Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas	NCT00005874	Gastrointestina... Sarcoma Small Intestine...	rubitecan	-	National Cancer Institute (NCI)
Radiation Therapy as Palliative Treatment of GIST	NCT00515931	Sarcoma	Radiation thera...	-	University of Helsinki
A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)	NCT01751919	Chronic Myeloid... Gastrointestina...	Imatinib mesyla... Glivec film-coa...	20 Years - 50 Years	Dong-A ST Co., Ltd.
A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor	NCT01874665	GIST	Ponatinib	18 Years -	Takeda
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)	NCT00075218	Gastrointestina...	Placebo SU011248	18 Years -	Pfizer
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate	NCT00265798	Gastrointestina...	Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)
A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors	NCT02686944	Gastrointestina...	Intuvax (ilixad...	18 Years -	Mendus
Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor	NCT02931981	Gastrointestina...	surgery or biop...	18 Years - 70 Years	RenJi Hospital
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	NCT03465722	GIST	avapritinib regorafenib	18 Years -	Blueprint Medicines Corporation
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma	NCT00006357	Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	imatinib mesyla...	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor	NCT00069940	Brain and Centr... Gastrointestina... Sarcoma	sargramostim telomerase: 540...	2 Years -	Dana-Farber Cancer Institute
S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors	NCT00005597	Gastrointestina...	temozolomide	18 Years -	SWOG Cancer Research Network
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)	NCT00075218	Gastrointestina...	Placebo SU011248	18 Years -	Pfizer
Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy	NCT03880617	CML GIST		-	National Taiwan University Hospital
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	NCT00777504	Renal Cell Carc... Gastrointestina...	usage oral angi... stop oral angio...	18 Years -	Radboud University Medical Center
Efficacy and Safety of PD-0332991 in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib	NCT01907607	Advanced Gastro...	PD 0332991	18 Years -	Institut Bergonié
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)	NCT00116935	Sarcoma	imatinib mesyla... imatinib imatinib	18 Years -	Scandinavian Sarcoma Group
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor	NCT00685828	Gastrointestina...	imatinib mesyla...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery	NCT00098579	Gastrointestina... Recurrent Adult... Stage IV Adult ...	alvocidib doxorubicin hyd...	18 Years -	National Cancer Institute (NCI)
A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)	NCT01751919	Chronic Myeloid... Gastrointestina...	Imatinib mesyla... Glivec film-coa...	20 Years - 50 Years	Dong-A ST Co., Ltd.
EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration	NCT01774162	Pancreas Adenoc... Pancreas Neopla... Gastrointestina... Lymphoma	Fine needle bio... Fine needle asp...	18 Years -	University of Alberta
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	NCT05160168	Gastrointestina... Neoplasms, Conn... Neoplasms, Conn... Neoplasms by Hi... Neoplasms Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina...	THE-630	18 Years -	Theseus Pharmaceuticals
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer	NCT02632448	Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc...	LY2880070 Gemcitabine	18 Years -	Esperas Pharma Inc.
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor	NCT00009906	Gastrointestina...	Imatinib Mesyla...	15 Years -	National Cancer Institute (NCI)
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	NCT00777504	Renal Cell Carc... Gastrointestina...	usage oral angi... stop oral angio...	18 Years -	Radboud University Medical Center
Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle	NCT01769248	Pancreatic Canc... Lymphadenopathy Gastrointestina...	Fine needle asp... Fine needle bio...	18 Years - 90 Years	Northwestern University
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST	NCT02164240	Gastrointestina...	Sunitinib Regorafenib	18 Years -	Dana-Farber Cancer Institute
Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas	NCT00005874	Gastrointestina... Sarcoma Small Intestine...	rubitecan	-	National Cancer Institute (NCI)
Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor	NCT00769782	Gastrointestina... Metastatic Canc...	therapeutic con...	20 Years -	Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy	NCT03880617	CML GIST		-	National Taiwan University Hospital
Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)	NCT01270893	Gastrointestina...	Nilotinib	18 Years -	M.D. Anderson Cancer Center
Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene	NCT01243346	D842-related Mu...	Crenolanib besy...	18 Years -	Arog Pharmaceuticals, Inc.
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors	NCT00573404	Gastrointestina...	imatinib mesyla... sunitinib malat... pharmacological...	18 Years -	Vanderbilt-Ingram Cancer Center
Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy	NCT01865565	Gastrointestina...		18 Years -	Chang Gung Memorial Hospital
EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration	NCT01774162	Pancreas Adenoc... Pancreas Neopla... Gastrointestina... Lymphoma	Fine needle bio... Fine needle asp...	18 Years -	University of Alberta
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Evaluation of Patients With Bulky GIST Using Sunitinib	NCT01054911	Tumor	Sunitinib Surgery	19 Years -	University of Alabama at Birmingham
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions	NCT02103322	Chronic Myeloid... Gastrointestina...	Imatinib Mesyla... Imatinib Mesyla...	18 Years - 55 Years	Amneal Pharmaceuticals, LLC
Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)	NCT01110668	Gastrointestina...	Nilotinib	18 Years -	Novartis
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial	NCT00640692	Gastrointestina...		18 Years - 80 Years	Oregon Health and Science University
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic	NCT01643278	Gastrointestina... Stage III Soft ... Stage IV Soft T...	Dasatinib Ipilimumab Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer	NCT00397384	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Carcinoma of th... Gastrointestina... Metastatic Gast... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Pancr... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Pancre... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Unresectable Ex... Unresectable Ga...	cetuximab erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate	NCT00956072	Gastrointestina...	imatinib mesyla... therapeutic con...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib	NCT01831726	Tumor Pathway A...	Dovitinib (TKI2...	18 Years - 100 Years	Novartis
S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors	NCT00005597	Gastrointestina...	temozolomide	18 Years -	SWOG Cancer Research Network
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate	NCT00265798	Gastrointestina...	Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor	NCT00103168	Gastrointestina...	imatinib mesyla...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors	NCT00372567	Gastrointestina...	sunitinib malat... imatinib mesyla...	18 Years -	Pfizer
Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery	NCT00041197	Gastrointestina...	imatinib mesyla... placebo laboratory biom...	18 Years -	National Cancer Institute (NCI)
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor	NCT00009906	Gastrointestina...	Imatinib Mesyla...	15 Years -	National Cancer Institute (NCI)
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions	NCT02103322	Chronic Myeloid... Gastrointestina...	Imatinib Mesyla... Imatinib Mesyla...	18 Years - 55 Years	Amneal Pharmaceuticals, LLC
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	NCT02834013	Acinar Cell Car... Adenoid Cystic ... Adrenal Cortica... Adrenal Gland P... Anal Canal Neur... Anal Canal Undi... Angiosarcoma Apocrine Neopla... Appendix Mucino... Bartholin Gland... Basal Cell Carc... Bladder Adenoca... Breast Metaplas... Cervical Adenoc... Cholangiocarcin... Chordoma Colorectal Squa... Desmoid Fibroma... Endometrial Tra... Endometrioid Ad... Esophageal Neur... Esophageal Undi... Extrahepatic Bi... Extramammary Pa... Fallopian Tube ... Fallopian Tube ... Fibromyxoid Tum... Gallbladder Car... Gastric Neuroen... Gastric Squamou... Gastric Undiffe... Gastrointestina... Gestational Tro... Giant Cell Carc... Human Papilloma... Intestinal Neur... Intrahepatic Ch... Lung Neuroendoc... Lung Sarcomatoi... Major Salivary ... Malignant Odont... Malignant Perip... Malignant Solid... Malignant Testi... Metastatic Mali... Metastatic Pitu... Minimally Invas... Mixed Mesoderma... Mucinous Adenoc... Mucinous Cystad... Nasal Cavity Ad... Nasal Cavity Ca... Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Oral Cavity Car... Oropharyngeal U... Ovarian Adenoca... Ovarian Germ Ce... Ovarian Mucinou... Ovarian Squamou... Ovarian Transit... Pancreatic Acin... Pancreatic Neur... Paraganglioma Paranasal Sinus... Paranasal Sinus... Parathyroid Gla... PEComa Penile Squamous... Peritoneal Meso... Placental Chori... Primary Periton... Pseudomyxoma Pe... Rare Disorder Scrotal Squamou... Seminal Vesicle... Seminoma Serous Cystaden... Small Intestina... Small Intestina... Spindle Cell Ne... Teratoma With S... Testicular Non-... Thyroid Gland C... Tracheal Carcin... Transitional Ce... Ureter Adenocar... Ureter Squamous... Urethral Adenoc... Urethral Squamo... Vaginal Adenoca... Vaginal Squamou... Vulvar Carcinom...	Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions	NCT02103322	Chronic Myeloid... Gastrointestina...	Imatinib Mesyla... Imatinib Mesyla...	18 Years - 55 Years	Amneal Pharmaceuticals, LLC
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma	NCT00041249	Gastrointestina... Sarcoma	brostallicin	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients	NCT01389583	Gastrointestina...	AUY922	20 Years - 75 Years	National Health Research Institutes, Taiwan
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors	NCT02508532	Gastrointestina... Other Relapsed ...	Avapritinib	18 Years -	Blueprint Medicines Corporation
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery	NCT02880020	Gastrointestina...	Ipilimumab Laboratory Biom... Nivolumab	18 Years -	Jonsson Comprehensive Cancer Center
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors	NCT01560260	Carney Complex Chondrosarcoma Gastrointestina... Paraganglioma	Laboratory Biom... Linsitinib Pharmacological...	18 Years -	National Cancer Institute (NCI)
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients	NCT01402089	Non Small-cell ... Renal-cell Canc... Gastrointestina...	Sunitinib Erlotinib Midazolam Caffeine	18 Years -	Cantonal Hospital of St. Gallen
Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor	NCT02931981	Gastrointestina...	surgery or biop...	18 Years - 70 Years	RenJi Hospital
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST	NCT01294202	Gastrointestina...	AT13387 and Ima...	18 Years -	Astex Pharmaceuticals, Inc.
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST	NCT05970900	Gastrointestina...	Imatinib Mesyla... Local resection	18 Years - 80 Years	Fujian Medical University Union Hospital
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors	NCT00372567	Gastrointestina...	sunitinib malat... imatinib mesyla...	18 Years -	Pfizer
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver	NCT00041808	Metastases, Neo... Colorectal Neop... Esophageal Neop... Stomach Neoplas... Pancreatic Neop... Breast Neoplasm... Melanoma Sarcoma Gastrointestina... Lung Neoplasms Liver Neoplasms Cholangiocarcin...	MTC-DOX for Inj... Chemotherapy	18 Years - 80 Years	FeRx
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer	NCT00005049	Colorectal Canc... Gastric Cancer Gastrointestina... Gastrointestina... Ovarian Cancer Peritoneal Cavi... Small Intestine...	carboplatin cisplatin floxuridine	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index	NCT02576080	Gastrointestina...	Imatinib Surveillance	18 Years - 80 Years	Assistance Publique Hopitaux De Marseille
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	NCT00777504	Renal Cell Carc... Gastrointestina...	usage oral angi... stop oral angio...	18 Years -	Radboud University Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: